Bayforest Capital Ltd Purchases 3,765 Shares of Exponent, Inc. $EXPO

Bayforest Capital Ltd raised its position in shares of Exponent, Inc. (NASDAQ:EXPO) by 73.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 8,914 shares of the business services provider’s stock after acquiring an additional 3,765 shares during the period. Bayforest Capital Ltd’s holdings in Exponent were worth $666,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of EXPO. Millennium Management LLC boosted its position in shares of Exponent by 543.1% in the 1st quarter. Millennium Management LLC now owns 305,230 shares of the business services provider’s stock worth $24,742,000 after purchasing an additional 257,766 shares in the last quarter. Cubist Systematic Strategies LLC bought a new position in Exponent in the 1st quarter valued at approximately $15,349,000. Geneva Capital Management LLC lifted its position in Exponent by 11.2% in the 1st quarter. Geneva Capital Management LLC now owns 1,745,828 shares of the business services provider’s stock valued at $141,517,000 after acquiring an additional 176,152 shares in the last quarter. Jacobs Levy Equity Management Inc. bought a new position in Exponent in the 1st quarter valued at approximately $12,686,000. Finally, Assenagon Asset Management S.A. bought a new position in Exponent in the 2nd quarter valued at approximately $9,993,000. 92.37% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Exponent presently has a consensus rating of “Hold”.

Exponent Price Performance

NASDAQ:EXPO opened at $65.86 on Tuesday. The firm has a market capitalization of $3.33 billion, a price-to-earnings ratio of 32.93 and a beta of 0.91. Exponent, Inc. has a one year low of $63.81 and a one year high of $115.75. The business has a fifty day moving average price of $69.86 and a 200-day moving average price of $74.09.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, topping the consensus estimate of $0.48 by $0.04. The firm had revenue of $132.87 million during the quarter, compared to analyst estimates of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.Exponent’s revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.57 EPS. On average, equities research analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Friday, September 5th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date was Friday, September 5th. Exponent’s dividend payout ratio is presently 60.00%.

Insiders Place Their Bets

In other news, VP Joseph Sala sold 1,595 shares of the firm’s stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total transaction of $112,670.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Catherine Corrigan sold 4,905 shares of the firm’s stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $69.91, for a total value of $342,908.55. Following the transaction, the chief executive officer owned 82,753 shares of the company’s stock, valued at approximately $5,785,262.23. The trade was a 5.60% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 11,396 shares of company stock valued at $803,636 in the last quarter. 1.60% of the stock is currently owned by company insiders.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.